Pure Global
NCT06368505

Platelet-Rich Plasma Injection Versus Hydrodissection in the Treatment of Carpal Tunnel Syndrome

A Prospective Comparative Study on the Efficacy of Ultrasound-Guided Platelet-Rich Plasma Injection Versus Hydrodissection in the Treatment of Carpal Tunnel Syndrome
Osama Ahmed Elshafei·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Carpal Tunnel Syndrome
Drug/Device/Intervention
ultrasound guided PRP injection
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Osama Ahmed Elshafei
Funder
Mansoura University
Location
Mansoura, Egypt
Timeline & enrollment
Phase
N/A
Start date
Jan 16, 2024
End date
Jul 16, 2024
Enrollment
64 participants
Primary outcome

Boston Carpal Tunnel Syndrome Questionnaire (BCTQ),The visual analog scale (VAS)

Summary

The goal of this clinical trial is to compare the efficacy of Ultrasound-Guided Platelet-Rich
 Plasma Injection versus Hydrodissection (using 2ml saline, 2ml dexamethasone and 1ml
 lidocaine) in the Treatment of Carpal Tunnel Syndrome. The main questions it aims to answer
 are:
 
 - Which modality is more effective in reducing symptoms and improving function in patients
 with Carpal tunnel syndrome
 
 - Asses safety profile of both methods
 
 Participants will:
 
 - Randomized to one of the two arms
 
 - Visit the clinic 1 and 3 months after intervention
 
 - Assessed for efficacy and safety of the intervention

ICD-10 classifications
Carpal tunnel syndromeTarsal tunnel syndromeArthrosis of first carpometacarpal joint, unspecifiedArthrosis of first carpometacarpal jointOther specified disorders of synovium and tendon
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06368505
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06368505 through Pure Global AI's free database. This phase not specified trial is sponsored by Osama Ahmed Elshafei and is currently Recruiting. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 64 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.